Figure 3
Liver function biomarker distributions of the patient groups. Lean patients have 18.5 kg/m2 ≤ BMI < 25 kg/m2. Patients with steatosis have SHAD ≥ − 1 HU or LMA < 40 HU. BMI body mass index, SHAD spleen-hepatic attenuation difference, LMA liver mean attenuation, ALP alkaline phosphatase, ALT alanine transaminase, AST aspartate transaminase.
